Enhance Mitochondrial Health & Visual Acuity in Dry AMD

Time: 2:45 pm
day: Track 2 Day 1 PM 1


  • Examine the rationale for mitochondrial targeted therapeutic for dry AMD and visual acuity endpoints in dry AMD
  • Investigate how phase 1 data demonstrates improved visual acuity with 6 mos. elamipretide therapy
  • Analyze Quantitative Compartmental OCT Analysis may predict response from baseline parameters of mitochondrial RPE health
  • Evelyne phase 2 trial design and baseline characteristics